Korean Society for Genetic Diagnostics Guidelines for Validation of Next-Generation Sequencing-Based Somatic Variant Detection in Hematologic Malignancies

키워드

참고문헌 (35)

1. Watson IR, "Emerging patterns of somatic mutations in cancer", Nat Rev Genet, 14, pp.703~718 (2013)
2. Coombs CC, "Molecular therapy for acute myeloid leukaemia", Nat Rev Clin Oncol, 13, pp.305~318 (2016)
3. Galanina N, "Comprehensive genomic profiling reveals diverse but actionable molecular portfolios across hematologic malignancies: implications for next generation clinical trials", Cancers (Basel), 11 (2018)
4. Vainchenker W, "Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms", Blood, 129, pp.667~679 (2017)
5. Grinfeld J, "Molecular determinants of pathogenesis and clinical phenotype in myeloproliferative neoplasms", Haematologica, 102, pp.7~17 (2017)
6. Ding L, "Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing", Nature, 481, pp.506~510 (2012)
7. Arber DA, "The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia", Blood, 127, pp.2391~2405 (2016)
8. Gerlinger M, "Intratumor heterogeneity and branched evolution revealed by multiregion sequencing", N Engl J Med, 366, pp.883~892 (2012)
9. Papaemmanuil E, "Genomic classification and prognosis in acute myeloid leukemia", N Engl J Med, 374, pp.2209~2221 (2016)
10. Goodman AM, "Next generation sequencing reveals potentially actionable alterations in the majority of patients with lymphoid malignancies", JCO Precis Oncol, 1, pp.1~13 (2017)
11. Taylor J, "Diagnosis and classification of hematologic malignancies on the basis of genetics", Blood, 130, pp.410~423 (2017)
12. Ballester LY, "Advances in clinical next-generation sequencing : target enrichment and sequencing technologies", Expert Rev Mol Diagn, 16, pp.357~372 (2016)
13. Kanagal-Shamanna R, "Principles of analytical validation of next-generation sequencing based mutational analysis for hematologic neoplasms in a CLIA-certified laboratory", Expert Rev Mol Diagn, 16, pp.461~472 (2016)
14. Yohe S, "Review of clinical next-generation sequencing", Arch Pathol Lab Med, 141, pp.1544~1557 (2017)
15. Swerdlow SH, "WHO classification of tumours of haematopoietic and lymphoid tissues", pp.16~27 (2017), International Agency for Research on Cancer
16. Jennings LJ, "Guidelines for validation of next-generation sequencing-based oncology panels : a joint consensus recommendation of the association for molecular pathology and college of American Pathologists", J Mol Diagn, 19, pp.341~365 (2017)
17. Gargis AS, "Assuring the quality of next-generation sequencing in clinical laboratory practice", Nat Biotechnol, 30, pp.1033~1036 (2012)
18. Matthijs G, "Guidelines for diagnostic next-generation sequencing", Eur J Hum Genet, 24, pp.1515~ (2016)
19. Döhner H, "Diagnosis and management of AML in adults : 2017 ELN recommendations from an international expert panel", Blood, 129, pp.424~447 (2017)
20. Li MM, "Standards and guidelines for the interpretation and reporting of sequence variants in cancer : A joint consensus recommendation of the association for molecular pathology, American Society of Clinical Oncology, and College of American pathologists", J Mol Diagn, 19, pp.4~23 (2017)
21. "Practice guidelines for targeted next generation sequencing analysis and interpretation"[URL]
22. Rehm HL, "ACMG clinical laboratory standards for next-generation sequencing", Genet Med, 15, pp.733~747 (2013)
23. Ben Lassoued A, "Minimal residual disease testing in hematologic malignancies and solid cancer", Expert Rev Mol Diagn, 14, pp.699~712 (2014)
24. "Oncology–molecular and cellular tumor markers “Next Generation” sequencing (NGS) guidelines for somatic genetic variant detection" (2018)[URL]
25. Beck TF, "Systematic evaluation of Sanger validation of next-generation sequencing variants", Clin Chem, 62, pp.647~654 (2016)
26. Van der Auwera GA, "From FastQ data to high confidence variant calls : the Genome Analysis Toolkit best practices pipeline", Curr Protoc Bioinformatics, 43, pp.11.10.1~11.10.33 (2013)[DOI]
27. Shin HT, "Prevalence and detection of low-allele-fraction variants in clinical cancer samples", Nat Commun, 8, pp.1377~ (2017)
28. Wala JA, "SvABA : genome-wide detection of structural variants and indels by local assembly", Genome Res, 28, pp.581~591 (2018)
29. Scheinin I, "DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly", Genome Res, 24, pp.2022~2032 (2014)
30. Levin JZ, "Targeted next-generation sequencing of a cancer transcriptome enhances detection of sequence variants and novel fusion transcripts", Genome Biol, 10, pp.R115~ (2009)
31. Kumar S, "Identifying fusion transcripts using next generation sequencing", Wiley Interdiscip Rev RNA, 7, pp.811~823 (2016)
32. Liu S, "Comprehensive evaluation of fusion transcript detection algorithms and a meta-caller to combine top performing methods in paired-end RNA-seq data", Nucleic Acids Res, 44, pp.e47~ (2016)
33. Zeng X, "A comprehensive overview and evaluation of circular RNA detection tools", PLoS Comput Biol, 13, pp.e1005420~ (2017)
34. Liu S, "Comprehensive evaluation of fusion transcript detection algorithms and a meta-caller to combine top performing methods in paired-end RNA-seq data", Nucleic Acids Res, 44, pp.e47~ (2016)
35. Singh RR, "Implementation of next generation sequencing in clinical molecular diagnostic laboratories : advantages, challenges and potential", Expert Rev Precis Med Drug Dev, 1, pp.109~120 (2016)

관련 논문AI추천